IL6 and cholangiocarcinoma: Accordingly, the protein abundance of p-Smad2, p-Smad3, α-SMA, vimentin, FAP (Fig. 6G), and IL-6 protein release level (Fig. 6H) in CAFs were reduced by CM derived from circ_0020256-silenced CCA cells.